+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

W13-P-026 The potential role of advanced glycation end products (Ages) in vascular smooth muscle cell proliferation and restenosis in diabetic vasculopathy



W13-P-026 The potential role of advanced glycation end products (Ages) in vascular smooth muscle cell proliferation and restenosis in diabetic vasculopathy



Atherosclerosis Suppl.s 6(1): 91-92




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067147463

Download citation: RISBibTeXText

DOI: 10.1016/s1567-5688(05)80363-0


Related references

Possible role of HMG CoA reductase inhibitor on the oxidative stress induced by advanced glycation endproducts(AGEs) in vascular smooth muscle cell(VSMC) of diabetic vasculopathy. 2007

Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy. Experimental and Molecular Medicine 41(11): 802-811, 2010

Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium. Cell Communication and Adhesion 22(2-6): 67-78, 2016

Involvement of Na+/H+ exchanger 1 in advanced glycation end products-induced proliferation of vascular smooth muscle cell. Biochemical and Biophysical Research Communications 375(3): 384-389, 2008

Role of peroxisome proliferators activated receptor y in mediating proliferation of rat vascular smooth muscle cells induced by advanced glycation end products. Zhonghua Xinxueguanbing Zazhi 33(10): 940-944, 2005

Recombinant Lapemis hardwickii phospholipase A2 inhibits rat vascular smooth muscle cell proliferation stimulated by advanced glycation end products. Di 1 Jun Yi Da Xue Xue Bao 23(3): 210-212, 2003

Role of peroxisome proliferators activated receptor gamma in mediating proliferation of rat vascular smooth muscle cells induced by advanced glycation end products. Zhonghua Xin Xue Guan Bing Za Zhi 33(10): 940-944, 2005

Smooth muscle cell pathophysiology and advanced glycation end products (AGEs). Current Drug Targets 11(7): 875-881, 2010

Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (Ages). Current Drug Targets 11(7): 875-881, 2010

The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications. Arquivos Brasileiros de Endocrinologia E Metabologia 52(6): 940-950, 2008

Effects of pioglitazone and irbesartan on vascular smooth muscle cells proliferation induced by advanced glycation end products. Zhongguo Xinyao yu Linchuang Zazhi 25(7): 501-504, 2006

Advanced glycation end products promote proliferation and suppress autophagy via reduction of Cathepsin D in rat vascular smooth muscle cells. Molecular and Cellular Biochemistry 403(1-2): 73-83, 2015

Advanced glycation end products promote the proliferation and migration of primary rat vascular smooth muscle cells via the upregulation of BAG3. International Journal of Molecular Medicine 39(5): 1242-1254, 2017

Peroxisome Proliferator-Activated Receptor Down-Regulates Receptor for Advanced Glycation End Products and Inhibits Smooth Muscle Cell Proliferation in a Diabetic and Nondiabetic Rat Carotid Artery Injury Model. Yearbook of Endocrinology 2007: 23-24, 2007

Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. Journal of Pharmacology and Experimental Therapeutics 317(1): 37-43, 2005